SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — History and Physical — Wilma Mankiller

PatientWilma Mankiller
Date of birth1991-11-18
IdentifiersMRN HR-ML052-SYN; SSN (made up) 000-52-4183
Document date2026-03-09
AuthorRena Hawkfeather-Lindqvist, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient with six weeks of drooping eyelids, double vision and fatigable weakness while recovering from a car crash: examination, ice pack test, breathing measurements, baseline tests, a pyridostigmine trial, kidney screening, and neuromuscular neurology referral [S]

History of Present Illness

This fictional modern episode addresses the presenting concerns below. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

8 later historical claims are omitted because they describe events after the index age. See the teaching note.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1979 (1978 in one account)Near-fatal head-on car crash with about 17 operations, with fractures of the legs, ribs and faceD (CLM-0005)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Pyridostigmine bromide 30 mg oral tablet, one tablet three times daily with meals as a trial; take 30 to 45 minutes before eatingOne tablet three times dailyOral route2026-03-09 to 2026-03-23completedS
Acetaminophen 500 mg oral tablet, one or two tablets up to three times daily as needed for leg painOne or two tablets up to three times daily as neededOral route2025-09-15activeS

Review of Systems

Positive for the concerns in the history of present illness. Alert, direct and composed; tired; speaks of the hard year since the crash and the loss of her friend; PHQ-9 score 7. No other systems reported as affected in this synthetic episode. [S]

General Status

Alert and engaged. Independent in daily activities; walks without help indoors and with a cane on rough ground after the leg operations; by evening she tires holding her arms up to brush her hair and must rest her jaw while eating. [S]

Physical Exam

Vital signs recorded on 2026-03-09; see the Vital Signs section. Mental status: Alert, direct and composed; tired; speaks of the hard year since the crash and the loss of her friend; PHQ-9 score 7. The physical examination is limited to the findings relevant to this synthetic episode. [S]

Vital Signs

DateMeasureValueUnitProvenance
2026-03-09Body height163cmS
2026-03-09Body weight61.8kgS
2026-03-09Body mass index (BMI) [Ratio]23.3kg/m2S
2026-03-09Systolic blood pressure126mm[Hg]S
2026-03-09Diastolic blood pressure82mm[Hg]S
2026-03-09Heart rate78/minS
2026-03-09Respiratory rate16/minS
2026-03-09Body temperature36.7CelS
2026-03-09Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-03-09Hemoglobin [Mass/volume] in Blood12.8g/dL11.6-15 g/dLNormalS
2026-03-09Leukocytes [#/volume] in Blood by Automated count6.910*3/uL4-11 10*3/uLNormalS
2026-03-09Platelets [#/volume] in Blood by Automated count26210*3/uL150-400 10*3/uLNormalS
2026-03-09Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-03-09Potassium [Moles/volume] in Serum or Plasma4.2mmol/L3.5-5.1 mmol/LNormalS
2026-03-09Glucose [Mass/volume] in Serum or Plasma88mg/dL70-99 mg/dLNormalS
2026-03-09Creatinine [Mass/volume] in Serum or Plasma0.78mg/dL0.59-1.04 mg/dLNormalS
2026-03-09Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M102mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-03-09Calcium [Mass/volume] in Serum or Plasma9.4mg/dL8.6-10.3 mg/dLNormalS
2026-03-09Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma18U/L7-45 U/LNormalS
2026-03-09Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma21U/L8-43 U/LNormalS
2026-03-09Albumin [Mass/volume] in Serum or Plasma4.2g/dL3.5-5 g/dLNormalS
2026-03-09Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.45-4.5 mIU/LNormalS
2026-03-09Hemoglobin A1c/Hemoglobin.total in Blood5.3%<=5.6%NormalS
2026-03-09Albumin/Creatinine [Mass Ratio] in Urine14mg/gBelow 30 mg/g is normal (A1)NormalS
2026-03-0925-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma31ng/mL30-100 ng/mLNormalS
2026-03-09Forced vital capacity [Volume] Respiratory system3.3LLower limit of normal about 2.9 L for her age, sex and heightNormalS
2026-03-09Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]7{score}S

Problems

ProblemClinical statusVerificationCodeProvenance
Drooping eyelids and double vision for six weeks, worse in the evening, with fatigable weakness of the arms and neck, tiring when chewing and a nasal voice after long talks; a disorder of the neuromuscular junction suspectedactiveconfirmed H53.2S — Synthetic presenting problem, resolved at the second visit when antibodies and nerve testing established myasthenia gravis.
Autosomal dominant polycystic kidney disease (hereditary, as she has described it), with normal kidney function; to be stagedactiveconfirmed Q61.2S — The hereditary polycystic kidney disease is documented (D) from her later public account; its detection before the index date, and every value, are synthetic.
Recovery from major trauma in a head-on car crash last year: fractures of both legs, ribs and face, with many operations; walks independently, with a cane on rough groundactiveconfirmed Z87.81S — The crash, the operations and the injuries are documented (D); the current function is synthetic.

Assessment

Plan of Treatment